+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States Orthobiologics Market Outlook to 2025

  • PDF Icon

    Report

  • 213 Pages
  • July 2018
  • Region: United States
  • GlobalData
  • ID: 4601566
Description Jump to:
United States Orthobiologics Market Outlook to 2025

Summary

The author's new report, United States Orthobiologics Market Outlook to 2025, provides key market data on the United States Orthobiologics market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories - Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Orthobiologics market categories - Bone Grafts and Substitutes, Bone Growth Stimulators, Soft Tissue Biologics and Viscosupplementation.

  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2015 to 2025.

  • 2017 company share and distribution share data for Orthobiologics market.

  • Global corporate-level profiles of key companies operating within the United States Orthobiologics market.

  • Key players covered include Medtronic plc, Sanofi, Stryker Corp and Others.


Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.

  • Develop market-entry and market expansion strategies.

  • Design competition strategies by identifying who-stands-where in the market.

  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 OrthobiologicsMarket Segmentation
2.3 Definitions of Markets Covered in the Report
3 Orthobiologics Market, United States
3.1 Orthobiologics Market, United States, Revenue ($m), 2015-2025
3.2 Orthobiologics Market, United States, Volume (Units), 2015-2025
3.3 Orthobiologics Market, United States, Average Price ($), 2015-2025
3.4 Orthobiologics Market, United States, Distribution Share by Revenue ($m), 2017
3.5 Orthobiologics Market, United States, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in United States, Orthobiologics Market
4.1 Medtronic Plc
4.2 Sanofi
4.3 DePuy Synthes Inc
4.4 Anika Therapeutics Inc
4.5 Fidia farmaceutici SpA
4.6 Stryker Corp
4.7 Zimmer Biomet Holdings Inc
4.8 DJO Global Inc
4.9 Seikagaku Corp
4.10 ConMed Corporation
4.11 LifeNet Health Inc
4.12 RTI Surgical Inc
4.13 Orthofix Holdings Inc
4.14 Bioventus LLC
4.15 Ferring Pharmaceuticals A/S
4.16 SeaSpine, Inc.
5 Orthobiologics Market Pipeline Products
6 Financial Deals Landscape
6.1 Debt Offerings
6.2 Equity Offerings
6.3 Partnerships
6.4 Private Equity
6.5 Venture Financing
7 Recent Developments
7.1 Corporate Communications
7.2 Financial Announcements
7.3 Government and Public Interest
7.4 Legal And Regulatory
7.5 Other Significant Developments
7.6 Product News
7.7 Strategy And Business Planning
8 Appendix
8.1 Research Methodology
8.2 Consulting
8.3 Contact
8.4 Disclaimer
List of Tables
Table 1: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 2: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 3: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 4: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 5: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 6: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 7: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 8: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 9: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2015-2020
Table 10: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2021-2025
Table 11: Orthobiologics Market, United States, Volume (Units), 2015-2020
Table 12: Orthobiologics Market, United States, Volume (Units), 2021-2025
Table 13: Bone Grafts and Substitutes Market, United States, Volume (Units), 2015-2020
Table 14: Bone Grafts and Substitutes Market, United States, Volume (Units), 2021-2025
Table 15: Bone Growth Stimulators Market, United States, Volume (Units), 2015-2020
Table 16: Bone Growth Stimulators Market, United States, Volume (Units), 2021-2025
Table 17: Soft Tissue Biologics Market, United States, Volume (Units), 2015-2020
Table 18: Soft Tissue Biologics Market, United States, Volume (Units), 2021-2025
Table 19: Viscosupplementation Market, United States, Volume (Units), 2015-2020
Table 20: Viscosupplementation Market, United States, Volume (Units), 2021-2025
Table 21: Orthobiologics Market, United States, Average Price ($), 2015-2020
Table 22: Orthobiologics Market, United States, Average Price ($), 2021-2025
Table 23: Orthobiologics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 24: Orthobiologics Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 25: Orthobiologics Market Pipeline Products
Table 26: Bone Biologics to Raise up to USD2 Million in Private Placement of 8.5% Notes Due 2019
Table 27: Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of 8.5% Convertible Promissory Note Due 2017
Table 28: Bone Biologics to Raise USD3.7 Million in Private Placement of Shares
Table 29: PolarityTE Prices Public Offering of Shares for USD55 Million
Table 30: Vericel Raises USD74.8 Million in Public Offering of Shares
Table 31: Integra LifeSciences Prices Public Offering of Shares for USD307 Million
Table 32: Alphatec Holdings Plans to Raise Funds through Public Offering of Shares
Table 33: PolarityTE Raises USD37.3 Million in Public Offering of Shares
Table 34: Histogenics Raises USD6.3 Million in Public Offering of Shares
Table 35: Ortho Regenerative Technologies Raises Funds through Private Placement of Shares and Warrants
Table 36: Alphatec Holdings Plans to Raise USD100 Million in Public Offering of Shares
Table 37: Bone Biologics Raises USD0.7 Million in First Tranche of Private Placement of Shares
Table 38: CellRight Technologies Enters into Distribution Agreement with Arthrex
Table 39: TPG Capital Amends Agreement to Acquire Exactech
Table 40: JANA Partners Denies Rumor to Acquire Certain Stake in Zimmer Biomet
Table 41: Carmell Therapeutics Raises USD0.4 Million in Financing
Table 42: Nanovis Raises USD0.7 Million in Financing
Table 43: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country
List of Figures
Figure 1: Orthobiologics Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 2: Bone Grafts and Substitutes Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 3: Bone Growth Stimulators Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 4: Soft Tissue Biologics Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 5: Viscosupplementation Market, United States, Revenue ($m), USD Constant, 2015-2025
Figure 6: Orthobiologics Market, United States, Volume (Units), 2015-2025
Figure 7: Bone Grafts and Substitutes Market, United States, Volume (Units), 2015-2025
Figure 8: Bone Growth Stimulators Market, United States, Volume (Units), 2015-2025
Figure 9: Soft Tissue Biologics Market, United States, Volume (Units), 2015-2025
Figure 10: Viscosupplementation Market, United States, Volume (Units), 2015-2025
Figure 11: Orthobiologics Market, United States, Company Share (%) 2017

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Medtronic Plc
  • Sanofi
  • DePuy Synthes Inc
  • Anika Therapeutics Inc
  • Fidia farmaceutici SpA
  • Stryker Corp
  • Zimmer Biomet Holdings Inc
  • DJO Global Inc
  • Seikagaku Corp
  • ConMed Corporation
  • LifeNet Health Inc
  • RTI Surgical Inc
  • Orthofix Holdings Inc
  • Bioventus LLC
  • Ferring Pharmaceuticals A/S
  • SeaSpine, Inc.

Related Topics

Related Reports

Orthobiologics Devices and Equipment Global Market Report 2024 - Product Image

Orthobiologics Devices and Equipment Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Orthobiologics Market - Forecasts from 2023 to 2028 - Product Image

Orthobiologics Market - Forecasts from 2023 to 2028

  • Report
  • 145 Pages
  • Global
From
Orthobiologics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029 - Product Image

Orthobiologics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

  • Report
  • 115 Pages
  • Global
From
Global Orthobiologics Market Analysis & Forecast to 2024-2034 - Product Image

Global Orthobiologics Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Global Orthobiologics Market by Type (Allografts, Bone Morphogenic Proteins, Demineralised Bone Matrix), Application (Fracture Recovery, Reconstructive Surgery, Soft-Tissue Injuries), End-User - Forecast 2024-2030 - Product Image

Global Orthobiologics Market by Type (Allografts, Bone Morphogenic Proteins, Demineralised Bone Matrix), Application (Fracture Recovery, Reconstructive Surgery, Soft-Tissue Injuries), End-User - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.